Biodesix

Jun 30, 2022

Philips Incorporating Biodesix Nodify Test Into Lung Cancer Patient Management System

Jun 3, 2022

Biodesix, Memorial Sloan Kettering Team on Minimal Residual Disease Test

May 11, 2022

Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results

Apr 11, 2022

Biodesix Raises $11.7M in Private Placement, Amends Loan Agreement

Mar 14, 2022

Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing

Mar 8, 2022

Biodesix Inks $50M Stock Sale Agreement

Jan 5, 2022

Biodesix Raises Approximately $16.3M in Sale of Common Shares, Amends $30M Term Loan

Dec 1, 2021

Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests

Nov 15, 2021

Biodesix Q3 Revenues Down 29 Percent on Lower COVID-19 Test Sales but Tops Estimates

Oct 27, 2021

Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians
Premium

Aug 10, 2021

Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations

May 11, 2021

Biodesix Q1 Revenues Soar on COVID-19 Testing

Apr 19, 2021

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market
Premium

Mar 24, 2021

Biodesix Secures $30M Term Loan

Mar 16, 2021

Biodesix Q4 Revenues More Than Triple on COVID-19 Testing

Mar 12, 2021

COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA
Premium

Feb 26, 2021

Reference Labs Take Diverse Approaches to Mitigating COVID-19 Sample Shipping Delays
Premium

Feb 18, 2021

In Brief This Week: Quest Diagnostics, Biodexis, Caris Life Sciences, SkylineDx, and More

Jan 13, 2021

Biodesix, HiberCell Partner to Develop Companion Diagnostic Test for Oncology Immunotherapy

Jan 8, 2021

Biodesix Preliminary Q4 Revenues Up Over 200 Percent